These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35372231)

  • 1.
    Zhang J; Yu F; Fu K; Ma X; Han Y; Ali CC; Zhou H; Xu Y; Zhang T; Kang S; Xu Y; Li Z; Shi J; Gao S; Chen Y; Chen L; Zhang J; Zhu F
    Front Public Health; 2022; 10():787299. PubMed ID: 35372231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene,
    Aoki S; Nakase K; Nakaminami H; Wajima T; Hayashi N; Noguchi N
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
    Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N
    J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutibacterium acnes: Much ado about maybe nothing much.
    van Steensel MAM; Goh BC
    Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH; Goh CL; Yeo MG; Tan ML
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
    Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
    J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.